Skip to main content
M

Maxigen Biotech Inc. — Investor Relations & Filings

Ticker · 1783 TW Manufacturing
Filings indexed 1,659 across all filing types
Latest filing 2025-08-11 Regulatory Filings
Country TW Taiwan
Listing TW 1783

About Maxigen Biotech Inc.

https://www.mbi.com.tw

Maxigen Biotech Inc. (MBI) is a medical device manufacturer specializing in the research, development, and production of biopolymer-based solutions, primarily focusing on collagen matrix and hyaluronic acid technologies. The company provides a comprehensive range of medical devices across multiple clinical disciplines, including orthopedics, aesthetics, ophthalmology, and wound care. Key products include hyaluronic acid intra-articular injections, dermal fillers, ophthalmic viscoelastics, collagen wound dressings, dental membranes, and synthetic bone grafts. In addition to its proprietary brands, MBI offers global OEM/ODM and customization services. The company adheres to international quality standards, holding certifications such as CE, FDA, NMPA, and MDSAP. MBI leverages its expertise in biopolymer science to deliver innovative medical and skincare products to international markets.

Recent filings

Filing Released Lang Actions
114年第2季綜合損益表
Regulatory Filings
2025-08-11 Chinese
114年第2季資產負債表
Regulatory Filings
2025-08-11 Chinese
公告本公司提報董事會2025年第2季合併財務報告
Regulatory Filings
2025-08-11 Chinese
114年07月內部人持股異動(事後)
Regulatory Filings
2025-08-06 Chinese
114年07月董事會成員及持股
Regulatory Filings
2025-08-06 Chinese
114年7月背書保證與資金貸與
Regulatory Filings
2025-08-05 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.